VP, Global Product Oncology
Amgen
Greenwood Village , CO, United States
David Raben, MD, FASTRO is a board-certified radiation oncologist and has served as an associate member of the University of Colorado Cancer Center, currently holding an adjoint professorship having recently held the Marsico Family Endowed Chair for Head and neck Cancer Research.
He received his undergraduate degree at Duke University (1981-1985) and his medical degree from Wake Forest University Health Sciences Center (1985-1990). Residency training in Radiation Oncology was conducted at the John Hopkins Hospital (1991-1994). He subsequently joined the Rdiation Oncology faculty at the University of Alabama at Birmingham from 1994-1998 followed by an appointment in Radiation Oncology at the University of Colorado in 1998. Dr. Raben has extensive expertise in the management of HNC, Lung, Prostate and Bladder cancer. From an academic research perspective, his focus has been on laboratory and translational discoveries related to radiation interactions with immune enabling drugs as well as DNA repair inhibitors and agents that affect TGFb signaling in HNC. Most recently, he along with the HNC research team was awarded the prestigious Specialized Programs of Research Excellence (SPORE) grant in HNC with his project having focused on combinatorial approaches to affect the tumor microenvironment to enhance anti-PD-L1 response. He led efforts to develop the first radiation Phase I Drug Development program at CU and initiated and completed multiple Phase I trials in HNC and Lung cancer. Dr. Raben served on the NRG Oncology HNC steering committee for the past 15 years. He also served as the Developmental Therapeutics Co-Chair at the NRG over the past 6 years. Dr. Raben jopined Genetech at 2019 to lead the late stage development franchise in lung, Skin and HNSCC areas of disease. More rently he joined Amgen in late 2021 as VP for Global Oncology Development.
Amgen (Individual(s) Involved: Self): Currently I am a full time employee of Amgen in Global Oncology Development as well as holding an Adjoint professorship at University of Colorado Health, Employment (full or part time)
Friday, March 11, 2022
1:15 PM – 2:05 PM US EST